Csequence Insights
Stay Informed and Educated with Csequence’s Blog
Unveiling the Genetic Landscape of Cannabis Use Disorder and Its Implications
This article is crucial as it sheds light on the intricate genetic relationships between cannabis use disorder (CanUD) and other substance use traits, providing valuable insights into the underlying mechanisms of substance dependence. Understanding these genetic influences is essential for informing evidence-based interventions, policy decisions, and public health strategies aimed at mitigating the risks associated with cannabis use and promoting healthier outcomes for individuals and communities.
An Overview of the Reclassification of Marijuana
Today is all about reclassifying marijuana from a Schedule I to a Schedule III drug and the impact it may have or may not have in the U.S. We’ve included a perspective from the Washington D.C.’s The Hill, Kyle Jaeger at Marijuana Moment, the ACLU and our own scientist Dr. Vita Maziveyi.
Exploring Potential Cannabis Reclassification: Opening the Doors for Cannabis Research
On June 4th, 2024, the National Center for Complementary and Integrative Health (NCCIH), a branch of the National Institutes of Health (NIH), will convene a landmark open meeting aimed at unlocking the mysteries of cannabis. With a keen focus on the plant’s potential in pain management, this gathering promises to unite leading NIH-funded researchers in a collaborative quest. By delving into the roles of minor cannabinoids and terpenes found within marijuana, experts seek to pioneer innovative solutions to one of healthcare’s most urgent challenges: effective pain relief.
Understanding the Dynamics of Tobacco and Cannabis Use During Pregnancy: Insights from the PATH Study
Understanding patterns of tobacco and cannabis use during pregnancy is crucial for safeguarding maternal and fetal health. The PATH study provides valuable insights into the prevalence of co-use before, during, and after pregnancy, highlighting the need for targeted interventions to support pregnant women in reducing substance use and protecting against adverse outcomes.
FDA to reschedule marijuana according to the Associated Press
According to Associated Press this morning the FDA will move to reclassify marijuana from a Schedule I to a Schedule III drug. Schedule I drugs have a high potential for abuse and no accepted medical use, while Schedule III drugs have a lower potential for abuse and accepted medical uses. The FDA’s plans were confirmed by five sources who spoke on condition of anonymity, but as of April 30 the FDA has made no official comment. The full impact of this change to consumers, retailers, regulators, states, and those serving prison sentences for possession in currently unknown.
Understanding the Neurocognitive Effects of CannEpil: Implications for Medicinal Cannabis Use
This article is important as it provides valuable insights into the acute neurocognitive effects of CannEpil, a medicinal cannabis oil, shedding light on its potential therapeutic benefits and safety profile in treating various medical conditions.
Americans continue to embrace cannabis and an improved outlook for hemp growers
All the news this week points to changing attitudes toward cannabis at both the federal and state level. Cannabis seems to be one thing Americans can agree on and the hemp industry settles down after a wild ride the past few years.
The Link Between Cannabis Use Disorder and Perioperative Complications: What You Need to Know
This study is important because it shows that people with cannabis use disorder have a slightly higher risk of complications and even death during major surgeries compared to those without the disorder. The findings suggest that healthcare professionals should screen for cannabis use disorder before surgeries to better assess risks and plan treatments, highlighting the need to understand and address the potential impact of cannabis use on patient safety as its use becomes more common in the United States.
Border patrol, states’ rights, and stormy seas for hemp retailers
Two stories today from Marijuana Moment as state and federal officials lock horns over legalization and states’ rights. Hemp retailers face stormy waters, with calls for more regulation and evidence of inaccurate labeling.
The Complex Relationship Between Cannabis Use and Cardiovascular Health
Cannabis, once considered a recreational substance with minimal health risks, has undergone a transformative shift in public perception and usage patterns. With the increasing prevalence of cannabis use across the United States, concerns regarding its potential health implications, particularly on cardiovascular health, have come to the forefront. A recent study delved into this critical issue, shedding light on the intricate association between cannabis use and cardiovascular outcomes among diverse segments of the population. Here, we dissect the findings of this study and explore the implications for individuals, healthcare professionals, and policymakers.